305 related articles for article (PubMed ID: 33069647)
1. Procedural Characteristics and Late Outcomes of Percutaneous Coronary Intervention in the Workup Pre-TAVR.
Faroux L; Campelo-Parada F; Munoz-Garcia E; Nombela-Franco L; Fischer Q; Donaint P; Serra V; Veiga G; Gutiérrez E; Vilalta V; Alperi A; Regueiro A; Asmarats L; Ribeiro HB; Matta A; Munoz-Garcia A; Armijo G; Urena M; Metz D; Rodenas-Alesina E; de la Torre Hernandez JM; Fernandez-Nofrerias E; Pascual I; Perez-Fuentes P; Arzamendi D; Campanha-Borges DC; Del Val D; Couture T; Rodés-Cabau J
JACC Cardiovasc Interv; 2020 Nov; 13(22):2601-2613. PubMed ID: 33069647
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Complex Coronary Artery Disease.
Alperi A; Mohammadi S; Campelo-Parada F; Munoz-Garcia E; Nombela-Franco L; Faroux L; Veiga G; Serra V; Fischer Q; Pascual I; Asmarats L; Gutiérrez E; Regueiro A; Vilalta V; Ribeiro HB; Matta A; Munoz-Garcia A; Armijo G; Metz D; De la Torre Hernandez JM; Rodenas-Alesina E; Urena M; Moris C; Arzamendi D; Perez-Fuentes P; Fernandez-Nofrerias E; Campanha-Borges DC; Mesnier J; Voisine P; Dumont E; Kalavrouziotis D; Rodés-Cabau J
JACC Cardiovasc Interv; 2021 Nov; 14(22):2490-2499. PubMed ID: 34794656
[TBL] [Abstract][Full Text] [Related]
3. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
4. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.
Chakravarty T; Sharma R; Abramowitz Y; Kapadia S; Latib A; Jilaihawi H; Poddar KL; Giustino G; Ribeiro HB; Tchetche D; Monteil B; Testa L; Tarantini G; Facchin M; Lefèvre T; Lindman BR; Hariri B; Patel J; Takahashi N; Matar G; Mirocha J; Cheng W; Tuzcu ME; Sievert H; Rodés-Cabau J; Colombo A; Finkelstein A; Fajadet J; Makkar RR
J Am Coll Cardiol; 2016 Mar; 67(8):951-960. PubMed ID: 26916485
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
7. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
8. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Coronary Intervention of Complex Calcific Coronary Lesions Utilizing Orbital Atherectomy Prior to Transcatheter Aortic Valve Replacement.
Beohar N; Mohammed N; Kherada N; Igyarto Z; Martinsen BJ
Cardiovasc Revasc Med; 2022 Apr; 37():82-85. PubMed ID: 34261617
[TBL] [Abstract][Full Text] [Related]
10. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
Puskas JD; Halkos ME; DeRose JJ; Bagiella E; Miller MA; Overbey J; Bonatti J; Srinivas VS; Vesely M; Sutter F; Lynch J; Kirkwood K; Shapiro TA; Boudoulas KD; Crestanello J; Gehrig T; Smith P; Ragosta M; Hoff SJ; Zhao D; Gelijns AC; Szeto WY; Weisz G; Argenziano M; Vassiliades T; Liberman H; Matthai W; Ascheim DD
J Am Coll Cardiol; 2016 Jul; 68(4):356-65. PubMed ID: 27443431
[TBL] [Abstract][Full Text] [Related]
12. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
[TBL] [Abstract][Full Text] [Related]
13. Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement.
Stephan T; Thoma E; Rattka M; Felbel D; Buckert D; Rottbauer W; Gonska B; Markovic S
BMC Cardiovasc Disord; 2021 Nov; 21(1):568. PubMed ID: 34847875
[TBL] [Abstract][Full Text] [Related]
14. Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
Kumar A; Sammour Y; Reginauld S; Sato K; Agrawal N; Lee JM; Meenakshisundaram C; Ramanan T; Kamioka N; Sawant AC; Mohananey D; Gleason PT; Devireddy C; Krishnaswamy A; Mavromatis K; Grubb K; Svensson LG; Tuzcu EM; Block PC; Iyer V; Babaliaros V; Kapadia S; Samady H
Catheter Cardiovasc Interv; 2021 Feb; 97(3):529-539. PubMed ID: 32845036
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of complex percutaneous coronary intervention in the pre-TAVR workup.
Avvedimento M; Campelo-Parada F; Nombela-Franco L; Fischer Q; Donaint P; Serra V; Veiga G; Gutiérrez E; Franzone A; Vilalta V; Alperi A; Regueiro A; Asmarats L; Ribeiro HB; Matt A; Muñoz-García A; Tirado G; Urena M; Metz D; Rodenas-Alesina E; Torre Hernández JM; Angellotti D; Fernández-Nofrerías E; Pascual I; Vidal-Calés P; Arzamendi D; Campanha-Borges DC; Trinh KH; Nuche J; Côté M; Faroux L; Rodés-Cabau J
Rev Esp Cardiol (Engl Ed); 2024 May; ():. PubMed ID: 38763211
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Outcomes of Transcatheter Aortic Valve Replacement Plus Percutaneous Coronary Intervention Versus Transcatheter Aortic Valve Replacement Alone in the United States.
Singh V; Rodriguez AP; Thakkar B; Patel NJ; Ghatak A; Badheka AO; Alfonso CE; de Marchena E; Sakhuja R; Inglessis-Azuaje I; Palacios I; Cohen MG; Elmariah S; O'Neill WW
Am J Cardiol; 2016 Dec; 118(11):1698-1704. PubMed ID: 27665205
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
18. Short- and Mid-Term Outcomes of Complex and High-Risk Versus Standard Percutaneous Coronary Interventions in Patients Undergoing Transcatheter Aortic Valve Replacement.
Kodra A; Basman C; Pirelli L; Wang D; Rahming H; Chaudhary R; Liu S; Mustafa A; Rutkin B; Maniatis G; Kalimi R; Wilson S; Yu PJ; Kim M; Singh V; Meraj P; Jauhar R; Kandov R; Gandotra P; Scheinerman SJ; Kliger C;
J Invasive Cardiol; 2023 Feb; 35(2):E92-E98. PubMed ID: 36525541
[TBL] [Abstract][Full Text] [Related]
19. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Percutaneous Coronary Intervention on Mortality in Patients With Coronary Lesions Who Underwent Transcatheter Aortic Valve Replacement.
van den Boogert TPW; Vendrik J; Gunster JLB; van Mourik MS; Claessen BEPM; van Kesteren F; Koch KT; Wykrzykowska JJ; Vis MM; Winkelman TA; Driessen AHG; Beijk MAM; de Winter RJ; Tijssen JGP; Planken NR; Baan J; Henriques JP
J Invasive Cardiol; 2021 Oct; 33(10):E823-E832. PubMed ID: 34609327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
